UN's sustainable development goals (SDG) analys
Camurus and the UN’s Sustainable Development Goals
Camurus’ sustainability work aims to contribute to the UN’s Sustainable Development Goals (SDGs). Of the UN’s 17 SDGs, Camurus has identified nine where the company sees the greatest potential for a positive impact. The table below shows how Camurus is contributing to the respecive selected SDGs.
| SDG | 3. Good health and well-being: Ensure healthy lives and promote well-being for all at all ages |
|---|---|
| Target: | 3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol |
| Camurus' contribution: | Opioid dependence is a serious, chronic, and relapsing disease that affects all aspects of a person’s life. It is also an escalating global health problem, contributing to significant negative consequences such as unemployment, criminal activity, imprisonment, transmission of infectious diseases, unintentional overdoses, and death. Opioid dependence is often associated with high social stigma and social exclusion. Camurus provides an opioid dependence treatment with demonstrated improved patient-reported outcomes, including higher treatment satisfaction, reduced treatment burden, and improved quality of life for patients with Buvidal compared to daily standard treatment.1-3 |
| Camurus goal: | Reach 100,000 patients in treatment with Buvidal® during 2026 |
| Target: | 3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all |
| Camurus' contribution: | Camurus' long acting medicines for treatment of severe and chronic diseases aim to create significant benefits for patients, caregivers, healthcare systems and society. By increasing the access to Camurus' medicines more people can be helped in attaining both better health and quality of life. An important step to increase access to treatment is to raise disease awareness and reduce potential stigma for those affected. In an effort to address this, Camurus supports and collaborates with healthcare and patient organizations to increase knowledge about serious and rare diseases. This work is conducted within the framework of the EFPIA (European Federation of Pharmaceutical Industries and Associations) guidelines and Camurus Healthcare Compliance program.The proper promotion and scientific exchange concerning Camurus products, as well as education about diseases and their management, adds important knowledge to the healthcare community, and is essential to ensure that as many patients as possible can have access to evidence based and qualitative care. Camurus' program, which includes our Healthcare Interactions Policy, procedures, guidelines, tools and training, is designed to ensure that all promotion and other information exchange is made in full compliance with regulations, laws, ethics and industry codes. |
| SDG: | 5. Gender Equality: Achieve gender equality and empower all women and girls |
|---|---|
| Target: | 5.5 Ensure women’s full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and public life |
| Camurus' contribution: | Camurus actively pursues diversity, equity and inclusion (DEI) work and strives for an equal gender distribution. Current gender distribution:
|
| Camurus' goal: | Gender distribution at Board and management level must in 2026 reflect the company as a whole (±20%) |
| SDG: | 6. Ensure availability and sustainable management of water and sanitation for all |
|---|---|
| Target: | 6.3 By 2030, improve water quality by reducing pollution, eliminating dumping and minimizing release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe reuse globally |
| Camurus' contribution: | Camurus is committed to use water efficiently and to prevent all releases of chemicals or pharmaceuticals into water, soil or air. Both within Camurus' own operations and within the outsourced manufacturing of products procedures are in place to prevent the release of chemicals or other polluting substances e.g. active pharmaceutical ingredient (API) or exipients to water. All process water (from production and lab) is collected and sent for destruction. |
| SDG: | 7. Ensure access to affordable, reliable, sustainable and modern energy for all |
|---|---|
| Target: | 7.2 By 2030, increase substantially the share of renewable energy in the global energy mix |
| Camurus' contribution: | Camurus is committed to using renewable energy and reducing its energy footprint throughout the value chain. Camurus procures renewable energy to the greatest extent possible in its own operations and challenges its vendors to use renewable energy. Actual share of renewble energy within own operations is 95%. |
| Camurus' goal: | From 2024 onwards, at least 80% of the energy used within Camurus’ operations to come from renewable sources |
| SDG: | 8. Decent work and economic growth: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all |
|---|---|
| Target: | 8.8 Protect labour rights and promote safe and secure working environments for all workers, including migrant workers,in particular women migrants, and those in precarious employment |
| Camurus' contribution: | Camurus' employees are Camurus' greatest asset. Camurus works actively to provide a sound and developing working environment that protects both the human rights and labor rights of all employees. Camurus actively pursues DEI work (diversity, equity and inclusion), and considers occupational health and safety work of critical importance. A majority of Camurus' employees are covered by collecting bargaining agreements. Given that global and complex supply chains often offer limited control and transparency, they can contain the risk of violations of human rights and labor rights, unsecure working environments, and discrimination. Camurus' vendors are required to comply with Camurus' Vendor Code of Conduct which challenges them to meet Camurus' sustainability standards, which include, amongst other things respect for human rights, labor rights, and the provision of decent working conditions. Camurus evaluates its vendors' compliance with the code and works actively together with its vendors to prevent and minimize sustainability risks within the supply chains. |
| Camurus' goal: | Healthy attendance over 97% in 2026 |
| SDG: | 10. Reduce inequalities within and among countries |
|---|---|
| Target: | 10.2 By 2030, empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status |
| Camurus' contribution: | Camurus works actively to improve access to treatment of opioid dependence and reduce stigma for people with opioid dependence, increasing the opportunity for everyone, regardless of socio-economic background, to participate in society on equal terms |
| Camurus' goal 2026: | Conduct annual projects focused on reducing stigma for patients |
| SDG: | 12. Responsible consumption and production: Ensure sustainable consumption and production patterns. |
|---|---|
| Target: | 12.2 By 2030, achieve the sustainable management and efficient use of natural resources |
| Camurus' contribution: | Camurus is committed to use resources efficiently, contribute to circularity, as well as preventing and minimizing pollution and emissions. Camurus' long-acting FluidCrystal technology utilizes both active pharmaceutical ingredient (API) and excipients efficiently compared to e.g. buprenorphine sublingual tablets. Water is a finite natural resource in growing demand. Water scarcity is an increasing problem on every continent. Camurus and its manufacturing vendor work actively to use water as efficiently as possible and reuse water where possible. Camurus also evaluates its vendors' water and resource management. Furthermore, Camurus strives to use raw material resources and energy as efficiently as possible both in its own operations and in the outsourced manufacturing process. Camurus' own operations use a high share of renewable energy and Camurus works actively to phase in renewable energy in transportation. In order to ensure product and patient safety the pharmaceutical industry is heavily regulated and resource use from e.g. packaging and product transportation is relatively high. In packaging there is a partly use of renewable material and Camurus is constantly working to reduce the environmental impact from packaging as well as from product transportation. |
| Target: | 12.5 By 2030, substantially reduce waste generation through prevention, reduction, recycling and reuse |
| Camurus' contribution: | Camurus is commited to preventing and reducing all kinds of waste (including hazardous waste). Both in Camurus' own operations and in manufacturing there is a waste management system in place for management and recycling of waste including hazardous waste. Camurus also evaluates its vendors' waste management and encourages structured waste management with focus on preventing and minimizing waste of all types. |
| SDG: | 13. Climate action: Take urgent action to combat climate change and its impacts |
|---|---|
| Target: | 13.1 Strengthen resilience and adaptive capacity to climate-related hazards and natural disasters in all countries 13.3 Improve education, awareness-raising and human and institutional capacity on climate change mitigation, adaptation, impact reduction and early warning |
| Camurus' contribution: | Camurus is commited to protecting the environment and proactively preventing and mitigating environmental pollution, including greenhouse gas emissions. Camurus works strategically to reduce its carbon footprint and increase climate adaptation throughout the value chain. Engagement of employees and vendors is key in this work. All employees receive training on the topic of sustainability which includes Camurus' environmental and sustainability policies and the company's carbon footprint reduction work. Camurus has set goals and developed an action plan to increase the share of renewable energy and achieve the transition to climate neutrality. All employees are delegated the responsibility to actively participate in Camurus' environmental and sustainability work. Camurus also collaborates with its vendors to reduce both carbon emissions, and other environmental footprints, and ultimately increase climate adaptation throughout the value chain. |
| Camurus' goal: |
|
| SDG: | 16. Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels |
|---|---|
| Target: | 16.5 Substantially reduce corruption and bribery in all their forms |
| Camurus' contribution: | Camurus' Business Ethics and Compliance Framework, which includes policies, procedures, controls and governance mechanisms, is designed to detect, prevent and address bribery and other forms of corruption. The framework is applied across the operations, with particular focus on measures that mitigate those risks in relation to the interactions with Camurus customers and other healthcare stakeholders, including interactions performed by Third Parties on Camurus' behalf. The framework is continously strengthened, through expanded policies, controls and training. These ensure oversight and monitoring of activities in the business, build ownership and awareness for ethics and compliance in the organization, and lower the resistance to raising difficult questions and reporting concerns. |
| Camurus' goal: |
|
References
- Lofwall MR, et al. JAMA Intern Med. 2018;178(6);764–773.
- Lintzeris N., et al. JAMA Network Open. 2021;4(5):e219041.
- Frost M., et al. Addiction. 2019;114:1416–1426.